Literature DB >> 7478605

Dissociation of transcriptional activation and oncogenic transformation by v-Myb.

R H Chen1, S Fields, J S Lipsick.   

Abstract

The nuclear oncoprotein v-Myb is a transcriptional activator in both animal cells and the budding yeast Saccharomyces cerevisiae. Previous studies have suggested that an acidic domain of approximately 50 amino acids (amino acids 204-254 of v-Myb) is necessary and sufficient for transcriptional activation by v-Myb, c-Myb and GAL4-Myb fusion proteins. However, we find that first, none of the acidic residues within this region is essential for transcriptional activation in either animal cells or yeast. Second, transcriptional activation requires cooperation among multiple domains of v-Myb. In animal cells, transcriptional activation by v-Myb requires a central domain (amino acids 234-295), a C-terminal domain (amino acids 295-356), plus either of two more N-terminal domains (amino acids 163-197 or 198-232); in yeast, it requires the central domain plus either the C-terminal domain or a more N-terminal domain (amino acids 163-233). Third, although various subsets of these domains are sufficient for transcriptional activation by v-Myb, all of the domains must be present for transformation of primary hematopoietic cells. These results demonstrate that transcriptional activation by v-Myb is not sufficient for oncogenic transformation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478605

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules.

Authors:  V Facchinetti; L Loffarelli; S Schreek; M Oelgeschläger; B Lüscher; M Introna; J Golay
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

2.  FAETL motif required for leukemic transformation by v-Myb.

Authors:  S L Fu; J S Lipsick
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Functional analysis of carboxy-terminal deletion mutants of c-Myb.

Authors:  D M Wang; J W Dubendorff; C H Woo; J S Lipsick
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Cells transformed by a v-Myb-estrogen receptor fusion differentiate into multinucleated giant cells.

Authors:  U Engelke; D M Wang; J S Lipsick
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain.

Authors:  B Ganter; S l Fu; J S Lipsick
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

6.  Overexpression of an alternatively spliced form of c-Myb results in increases in transactivation and transforms avian myelomonoblasts.

Authors:  C H Woo; L Sopchak; J S Lipsick
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 7.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

8.  Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis.

Authors:  S E Salghetti; M Muratani; H Wijnen; B Futcher; W P Tansey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.